CEO Liquidates All Shares of Boston Scientific, Raising Questions Over Company’s Future Confidence.
Boston Scientific CEO’s 386,755‑share sale signals potential confidence shift; investors weigh insider move against strong product pipeline and market upside.
3 minutes to read



